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The aim of this study was to systematically investigate the effectiveness of hatha yoga in
treating acute, chronic and/or treatment-resistant mood and anxiety disorders.
Methods
Medline, Cochrane Library, Current Controlled Trials, Clinical Trials.gov, NHR Centre for
Reviews and Dissemination, PsycINFO and CINAHL were searched through June 2018.
Randomized controlled trials with patients with mood and anxiety disorders were included.
Main outcomes were continuous measures of severity of mood and anxiety symptoms.
Cohen’s d was calculated as a measure of effect size. Meta-analyses using a random
effects model was applied to estimate direct comparisons between yoga and control condi-
tions for depression and anxiety outcomes. Publication bias was visually inspected using
funnel plots.
Results
Eighteen studies were found, fourteen in acute patients and four in chronic patients. Most
studies were of low quality. For depression outcomes, hatha yoga did not show a significant
effect when compared to treatment as usual, an overall effect size of Cohen’s d -0.64 (95%
CI = -1.41, 0.13) or to all active control groups, Cohen’s d -0.13 (95% CI = -0.49, 0.22). A
sub-analysis showed that yoga had a significant effect on the reduction of depression com-
pared to psychoeducation control groups, Cohen’s d -0.52 (95% CI = -0.96, -0.08) but not to
other active control groups, Cohen’s d 0.28 (95% CI = -0.07, 0.63) For studies using a fol-
low-up of six months or more, hatha yoga had no effect on the reduction of depression com-
pared to active control groups, Cohen’s d -0.14 (95% CI = -0.60, 0.33). Regarding anxiety,
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hatha yoga had no significant effect when compared to active control groups, Cohen’s d
-0.09 (95% CI = -0.47, 0.30). The I2 and Q-statistic revealed heterogeneity amongst com-
parisons. Qualitative analyses suggest some promise of hatha yoga for chronic populations.
Conclusions
The ability to draw firm conclusions is limited by the notable heterogeneity and low quality of
most of the included studies. With this caveat in mind, the results of the current meta-analy-
sis suggest that hatha yoga does not have effects on acute, chronic and/or treatment-resis-
tant mood and anxiety disorders compared to treatment as usual or active control groups.
However, when compared to psychoeducation, hatha yoga showed more reductions in
depression. It is clear that more high-quality studies are needed to advance the field.
Introduction
Worldwide, mood and anxiety disorders represent the two most common forms of mental dis-
orders [1]. For example, it has been estimated that nearly 28% of Europeans and 55% of Ameri-
cans experience one of these disorders during their life [2, 3]. Further, research has consistently
shown a relation between these disorders, as demonstrated by their high rates of comorbid
symptoms [4, 5]. Given that mood and anxiety disorders are characterized by the presence of
negative affect [6], a number of theorists propose that difficulty in regulating negative affect rep-
resents a psychological mechanism for both disorders [7, 8]. Examples of difficulties in regulat-
ing negative affect include repetitive negative thinking [9–11] and emotional and behavioral
avoidance [12].
A large proportion of individuals have chronic forms (over two years [13]) of mood and anx-
iety disorders. Chronicity is exhibited by approximately 25% of individuals with a mood disor-
der and 40% of individuals with an anxiety disorder [14]. Chronicity in these disorders is
associated with higher health care use, lower social-economic functioning, reduction in work
productivity, and lower quality of life compared to acute forms of disorders [15–18].
Cognitive-behavioral therapy and pharmacotherapy have been shown to improve acute
symptoms [19–21], but the benefits of current first-line treatments for acute patients are mod-
est, as indicated by medium to small effect sizes [19, 21] and rates of nonresponse to treatment,
ranging from 19–34% [22, 23]. Chronically depressed patients experience even fewer benefits
from therapy, as indicated by small effect size outcomes [24]. Epidemiological studies have
suggested that anxiety disorders tend to be chronic at even higher rates than mood disorders
[18, 25, 26]. A proportion of individuals with chronic forms of mood and anxiety disorders are
those who are treatment-resistant. Although the field lacks a consensus of how to define treat-
ment-resistance, there is some general agreement that treatment resistance involves no or only
partial improvement from pre- to post-intervention (after treatment of adequate dose and
duration [27–30]). It is estimated that 30–40% of patients recover with standard treatment and
another 30–40% can be considered partially improved [29, 30]. In sum, the research reviewed
above makes it clear that a large number of patients with mood and anxiety disorders do not
(fully) respond to treatment, leaving many patients with chronic forms of these disorders.
Therefore, it is important to continue searching for new approaches to target the difficulty of
regulating negative affect and prevent chronicity in mood and anxiety disorders.
One new approach for treating mood and anxiety disorders is hatha yoga, a form of yoga
that uses physical postures in combination with breathing and/or meditation practices [31].
Hatha yoga may be well suited as an intervention for mood and anxiety disorders given initial
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findings that hatha yoga helps to lessen psychological distress [32, 33]. Hatha yoga has also
been shown to influence transdiagnostic processes underlying mood and anxiety disorders,
such as repetitive negative thinking [34, 35] and avoidance of negative emotions [36–38]. Fur-
ther, hatha yoga involves elements of physical exercise and meditation, both of which have
been shown to be useful in treating psychological distress [39–41] and in influencing the trans-
diagnostic processes of repetitive negative thinking [42, 43] and avoidance of negative emo-
tions [44, 45].
Yoga also holds promise as an intervention due to its acceptability. Intervention acceptabil-
ity is an important variable given that the majority of individuals suffering from mood and
anxiety disorders do not seek treatment [46] and that among treatment seekers, a substantial
percent drop out of treatment [47, 48]. Evidence for the acceptability of yoga includes that it is
widely embraced by the public [49] and is increasingly sought as a means of treating depres-
sion and anxiety [50].
The effects of yoga on mood and anxiety disorders have been reviewed by several authors
[51–59]. These systematic reviews and two meta-analyses concluded that there is some evidence
of yoga being effective for mood and anxiety disorders, but all mention serious methodological
drawbacks of the included randomized controlled trials (RCTs). An important limitation of
these reviews is that they included studies with both nonclinical and clinical samples, making it
difficult to draw conclusions regarding the efficacy of yoga for patients. Additionally, neither
the meta-analyses nor the systematic reviews examined the effects of yoga for chronic and/or
treatment-resistant populations. Understanding the efficacy of yoga for these populations is
important, given that these forms of mood and anxiety disorders are associated with poorer
treatment outcomes and greater economic and other societal costs [24]. Another limitation of
these reviews is that they included a diverse range of yoga interventions, ranging from medita-
tion-only to complex interventions involving yoga postures, meditation, breath work, and life-
style modifications. Such heterogeneity obscures the ability to draw conclusions about the
benefits of yoga as it is difficult to distinguish which of the diverse forms are helpful and which
are not.
We therefore conducted a systematic review and meta-analysis to answer two questions: (1)
is hatha yoga an effective treatment for acute mood and anxiety disorders, and (2) is hatha yoga
an effective treatment for chronic and/or treatment-resistant mood and anxiety disorders?
Methods
This systematic review and meta-analysis was planned and conducted following the guidelines
of the PRISMA statement [60].
Search
A clinical librarian searched the existing literature for articles describing RCTs for yoga inter-
ventions in adult clinical samples with mood and anxiety disorders with the following search
terms: (MH "Yoga" OR yog OR asana OR pranayama OR dhyana) (the last three being San-
skrit terms for the different components of yoga: postures, breathing exercises and meditation)
AND (MH "Depression" OR MH "Depressive Disorder+" OR MH "Anxiety+" OR MH "Anxi-
ety Disorders+" OR MH "Mood Disorders+" OR depress OR dysthym OR anx OR MDD
OR GAD OR mood OR affective). We searched both relevant Medical Subject Headings and
free-text terms. The following databases were searched until June 2018: Medline, Cochrane
Library, Current Controlled Trials, Clinical Trials.gov, NHR Centre for Reviews and Dissemi-
nation, PsycINFO and CINAHL. Additionally, reference lists of relevant review papers
extracted from the database search were manually reviewed.
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Selection of trials
Two independent reviewers (AABV and NKV) selected studies if they: (1) were an RCT, com-
paring a yoga intervention to a wait-list control group, treatment as usual (TAU) or an active
control (e.g., exercise or relaxation), (2) included a hatha yoga intervention that incorporated
physical postures based on yoga theory, possibly also including meditative practices and/or
breathing practices, (3) included a majority of patients with major depression, dysthymic dis-
order, generalized anxiety disorder, social anxiety disorder, or panic disorder (as these three
anxiety disorders are considered closely related according to DSM-V [13]), diagnosed with the
criteria of the International Classification of Disease 10 (ICD-10 [61]) or the Diagnostic and
Statistical Manual, Fourth Edition (DSM-IV [62]), or older versions of the DSM (including
DSM-I [63], DSM-II [64] and DSM-III [65], using older terms referring to the three included
anxiety disorders, including anxiety neurosis and psychoneurosis [66] or older terms referring
to various types of depression, including neurotic and reactive depression [66]), (4) included
adult samples (ages 18–65 years), (5) were written in the English language, (6) did not describe
the same study (or part of a study) of another article, and (7) included either a continuous
measure of improvement or a dichotomous measure of remission of mood and/or anxiety
symptoms at both pre- and post-intervention, using validated self-report scales (e.g., Beck
Depression Inventory, BDI [67]), or clinician-rated scales (e.g., Hamilton Rating Scale for
Depression, HRSD [68]).
Mindfulness-based stress reduction (MBSR) and mindfulness-based cognitive therapy
(MBCT) interventions were excluded because these have more focus on sitting meditation and
body scans, with yoga being only a small part of these interventions. No restrictions were
made regarding yoga tradition, intervention length or frequency. Studies that paired yoga with
other interventions such as treatment as usual were also included.
Data extraction
Major characteristics of the included studies were coded by two independent reviewers (AABV
and NKV), including outcome variables (symptoms of depression and/or anxiety), patient charac-
teristics (diagnosis, based on which diagnostic interview, inpatients or outpatients), intervention
characteristics (type of yoga, length of the sessions, duration of the intervention, homework), con-
trol group characteristics (type of control group, length of the session, duration of the interven-
tion, homework), and general characteristics (co-interventions, number of patients per group).
The population of the study was coded as acute or chronic and/or treatment-resistant. We defined
chronic as: having a mood or anxiety disorder for over two years, without full remission [13]. We
defined treatment-resistant as: having received at least two standard interventions of adequate
dose and duration (pharmacotherapy or a psychological intervention), without full remission
[30]. If the majority of a study sample was diagnosed with a chronic and/or treatment-resistant
depression or anxiety disorder, we classified this study as chronic and/or treatment-resistant. Dis-
agreements were discussed with a third reviewer (HJRH) until agreement was reached.
Effect size calculations
The primary outcome measure in the meta-analysis was the standardized mean change in
symptoms of depression and/or anxiety. For primary outcome measures, the standardized
mean change (Cohen’s d) between the baseline and post-treatment assessment for each treat-
ment condition (intervention and control groups) in the studies was calculated. The following
equation was used [69]:
Cohen0s d ¼ ðMT1   MT0Þ=SDT0
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with MT1 as the mean of the post-treatment outcome measure and MT0 the mean of the base-
line outcome measure. SDT0 indicates the standard deviation of the baseline outcome measure.
For the follow-up effect sizes, MT1 represented the mean of the follow-up outcome measure
and MT0 the mean of the post-treatment outcome measure, whilst SDT0 stood for the standard
deviation of the post-treatment outcome measure.
The overall effect size comparing the yoga intervention group to the control group, was cal-
culated with the subsequent equation:
Cohen0s d ðtreatment vs: controlÞ ¼ dintervention   dcontrol
with dintervention as the effect size of the intervention group and dcontrol for the effect size of the
control group.
The Standard Error (S.E.) of the Cohen’s d was calculated, used to weigh effect sizes when
combining studies, so that large studies are considered more important than small studies in
the analysis, using the following equation [70]:






with n representing the number of participants in the treatment arm, r representing for the
baseline to post-treatment correlation and d representing the effect size as calculated by
Cohen’s d. This was calculated separately for the yoga group and the control group.
To calculate the S.E. for the overall Cohen’s d for yoga vs. control, the S.E. of the control
group must be added to the S.E. of the yoga group, and subsequently the square root of this
value must be computed.
When a study used more than one relevant active intervention as a control condition, we
used a combined effect size of the two active interventions because two separate outcomes
from the same study (and the same participants) cannot be entered into one meta-analytic
pooled effect size, as the outcomes are not independent from each other and the errors are cor-
related [71]. The combined effect size for these studies was calculated with the following equa-
tion [71]:




with d1 representing the effect size of the yoga group compared to the first active intervention
and d2 representing the effect size for the yoga group compared to the second active
intervention.
To calculate a combined standard error, the following equation was used [71]:





with S.E.1 representing the Standard Error of the effect size of the yoga group compared to the
first active intervention and S.E.2 representing the Standard Error of the effect size of the yoga
group compared to the second active intervention. The r represents the correlation between
the two active control conditions.
Quality assessment
To assess the quality of the studies, two independent raters (AABV and NKV) assessed the
studies using the Clinical Trials Assessment Measure for psychological treatments (CTAM
[72]), a rating scale designed to assess the quality of psychological interventions in mental
health care. The scale assesses six aspects of the design of the trial: (1) sample size and how the
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sample was recruited, (2) allocation of treatment, (3) assessment of the outcome measures, (4)
type of control group, (5) statistical analyses, and (6) description of the intervention. The
CTAM score ranges from 0 to 100, with a score above 65 considered to be adequate. Disagree-
ments were discussed with a third reviewer (HJRH) until agreement was reached. The scale
had a good blind inter-rater agreement of .96 and a sufficient internal consistency with a Cron-
bach’s alpha of .70 [73].
Statistical analysis
Statistical analyses were performed using R software, with the metaphor package [74]. A meta-
analysis using a random effects model was applied to estimate direct comparisons between
yoga and control conditions for both depression and anxiety outcomes. Heterogeneity was
assessed using the Q and I2 statistic [75], to examine and quantify whether the variability in
estimates of effect sizes from similar studies excels the variation expected from sampling error.
If the Q statistic is non-significant, this indicates that there is no significant heterogeneity and
Cohen’s d can be reliably interpreted. I2 was interpreted and quantified as low, moderate, and
high to values of 25%, 50%, and 75% [76]. Publication bias was assessed using the Egger’s test
and funnel plots [77]. If the p-value of the Egger’s test is 0.1 or lower, and the funnel plots
appear asymmetric, there is an indication for publication bias.
Results
Search results
An overview of the selection process and included studies is given in Fig 1. The search in the
aforementioned databases resulted in 2,318 articles for screening, with three additional articles
identified via cross-reference searching. Of the 2,321 articles, 409 abstracts were screened. A
further 113 articles were excluded based on their abstract, using the criteria mentioned in the
Methods section. After a full-text screening of the remaining articles, 18 studies (in 20 articles)
were included.
Characteristics of included studies
The final 18 trials were divided into studies with acute clinical populations (n = 14) and studies
with chronic and/or treatment-resistant clinical populations (n = 4). Selected characteristics of
the included studies are presented in Table 1 for acute populations and in Table 2 for chronic
populations. The total number of participants was 1,532 with sample sizes ranging from 12 to
620 participants (mean = 85). Approximately 561 participants received a yoga intervention
(one study did not report the number of participants per group [78]). The majority of the par-
ticipants was female (78.7%, n = 1,072), with seven studies including only women [34, 35, 78–
82]. Three studies did not report the gender of the participants [83–85]. The mean age was
36.6 years (SD 9.1; range 22.1–50.4). The studies were performed in the United States [35, 79–
82, 86–90], India [78, 83–85, 91, 92], Sweden [93], and Germany [94].
Ten studies were aimed at patients with an acute mood disorder: major depressive disorder
[35, 81, 82, 89, 92, 94], major depressive disorder and dysthymia [79, 80, 86] and neurotic or
reactive depression [91]. Two studies were aimed at patients with an acute anxiety disorder:
anxiety neurosis or psychoneurosis [84] and an anxiety disorder that was not further specified
[78]. Two studies included patients with a depressive disorder and/or an anxiety disorder [88,
93].
We found one study in patients with a chronic major depressive disorder (dysthymia, dou-
ble depression, and major depressive disorder; defined as having experienced symptoms for
Hatha yoga for mood and anxiety disorders
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over two years, without significant remission of two months or more [87]), one study in which
almost two thirds of the sample had chronic major depression (defined as reporting symptoms
over the past two years with absence of remission over two months [90]), one study in patients
with treatment-resistant psychoneurosis or depression (defined as absence of response to con-
ventional treatments, without defining these treatments [85]) and one study in which the
majority of patients (58.33%) had a chronic generalized anxiety disorder (defined as 3–5 years
of symptoms [83]). In one study the sample was described as chronically depressed using the
Fig 1. Flow chart of the study selection process and included studies.
https://doi.org/10.1371/journal.pone.0204925.g001
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definition of being depressed at least from the onset of pregnancy [80]. As this did not meet
our definition of chronicity, this study was considered as aimed at acute patients.
Diagnoses were made with the Structured Clinical Interview for the DSM-IV [95; 35, 79–
81, 82, 87, 90, 94] and the MINI International Neuropsychiatric Interview [96; 86, 89, 93]. In






































































































































































































Note 1. CBT, Cognitive Behavioral Therapy; CDRS-SR, Cornell Dysthymia Rating Scale; dif, difference; HAM-A, Hamilton Rating Scale for Anxiety; HAM-D, Hamilton
Rating Scale for Depression; LoE, Level of Evidence; MDE, Major Depressive Episode; min, minutes; MINI, MINI International Neuropsychiatric Interview; QIDS,
Quick Inventory of Depressive Symptomatology; SCID, Structured Clinical Interview for DSM-IV; sig, significant; TOP, Treatment Outcome Package; sign, significant;
TAS, Taylor’s Anxiety Scale;
 Number of patients that received the yoga intervention.
https://doi.org/10.1371/journal.pone.0204925.t002
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three studies, the diagnosis was made by a psychiatrist or other health care professional, based
on the DSM-IV or an earlier version, without mentioning how this diagnosis was established
[84, 88, 91]. In four studies, it was unclear how and by whom the DSM-diagnosis was estab-
lished [78, 83, 85, 92].
Large differences were observed between the trials in terms of treatment dosage, amount of
homework practice, comparison groups, and follow-up duration. Length of the intervention
varied between three days [91] and twelve weeks [35, 79–81, 84, 87, 92, 93]. The amount of
practice ranged from 120 minutes a day [92] to 20 minutes a week [79, 80]. In ten studies,
daily (home) practice was encouraged, at least for five days a week [78, 82, 84–88, 90–92]. In
five studies, it was unclear how often or whether participants were encouraged to practice at
home [79–81, 89, 94]. Most studies did not include a longer follow-up period, except for seven
studies that used a follow-up postpartum [79], at 4 weeks [35, 88], at 3 months [90], at 6
months [90], at 9 months [87], and after one year [34, 97].
Most studies reported baseline and post-treatment means but five studies only reported the
mean change of the outcome measure [83, 84], the percentage of change [90, 91], the differ-
ence between time points [97] or means at follow-up only [86, 34]. These authors were con-
tacted for the separate baseline and post-treatment means in order to be able to
homogeneously calculate the effect sizes for all studies. Two studies did not report the standard
deviations of the means [78, 89] and one study did not report the means and standard devia-
tions for the post-treatment assessment [94]. These authors were contacted for the means and
standard deviations in order to be able to calculate the effect sizes for all studies. Three authors
(or colleagues in their department) were unable to provide the requested data [83, 84, 91], and
one author did not respond despite repeated efforts to make contact [78]. The data from these
four studies were excluded from the meta-analysis.
Only one study used dichotomous outcomes of depression [87]. If studies reported multiple
assessment points after baseline, only those assessed immediately after treatment were used.
The baseline to post-treatment correlation and the correlation between active control condi-
tions [93] was not reported in the included articles. In line with recommendations from previ-
ous research [39], we assumed a conservative baseline to post-treatment correlation of 0.7 for
all studies. For the correlation between active control conditions, we assumed a correlation of
0.5 in line with recommendations by Borenstein [71]. A sensitivity analysis around this corre-
lation provided support for its use.
Outcome measures
Fifteen RCTs assessed symptoms of depression, using the Beck Depression Inventory [35, 88,
89, 92], Center of Epidemiological Studies Depression Scale [79–81], Quick Inventory of
Depressive Symptomatology [82, 90], Edinburgh Postnatal Depression Scale [79, 82], Hamilton
Depression Rating Scale [87, 94], Patient Health Questionnaire [86, 90], Cornell Dysthymia Rat-
ing Scale-Self Report [87], Montgomery-Asberg Depression Rating Scale [93], Profile of Mood
States [79], Symptom Sign Inventory [84], or a personalized assessment of symptoms [91].
Eight RCTs assessed symptoms of anxiety, using the State-Trait Anxiety Inventory [79, 80, 86],
the Hamilton Anxiety Rating Scale [83, 88], the Taylor’s Anxiety Scale [78, 85], and the IPAT
Anxiety Scale [84]. Only one RCT assessed remission rates, using the Structured Clinical Inter-
view for the DSM-IV to obtain remission rates [87]. Since for this study we also had continuous
outcomes available we used the highest ranked continuous outcome measure for our analyses.
When a study assessed the outcome variable using multiple measurement scales [79, 82, 87,
90], we selected the most suitable depression scale, based on a preferred hierarchy of depres-
sion scales, determined post-hoc (Table 3). This hierarchy was based on the available evidence
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on the reliability and validity of the scale as an assessment tool for depression, and was deter-
mined in consensus with NKV and AABV. For Butler and colleagues [87], the preferred scale
was the Hamilton Depression Rating Scale, for Field and colleagues [79], this was the Center of
Epidemiological Studies Depression Scale, and for both studies of Uebelacker and colleagues
[82, 90], this was the Quick Inventory of Depressive Symptomatology.
Comparison groups
For the meta-analysis, we divided the comparison groups into active interventions and treat-
ment as usual (TAU) interventions. One study used ‘no intervention’ as control group [88].
Given that at least a quarter of participants received TAU, we considered the control group of
this study as TAU. We compared yoga with a general grouping of active interventions and,
when there were enough studies to do so, with sub-groups of active interventions, consisting
of psychoeducation control groups (e.g., interventions controlling only for non-specific factors,
for instance healthy living classes) and other active interventions (e.g., interventions controlling
for non-specific factors as well as therapeutic factors, for instance mindfulness or walking).
Four studies included in the meta-analysis used more than one comparison group which
could not be entered together into one pooled effect size [71]. In two studies [80, 88], the first
comparison group was an active intervention and the second comparison group was TAU, so
these groups are included in separate analyses (yoga vs. active control and yoga vs. TAU). One
study [93] used a TAU condition, as well as two active interventions of different intensity
(intermediate-level aerobics and more strenuous aerobics). As both active interventions were
similar with a different intensity, we used a combined effect size for this comparison [71]. One
study [87] used two active comparison groups. One group was a psychoeducation group and
the other group also consisted of other therapeutic ingredients (group therapy with hypnosis)
so these groups were included in the separate analyses for active interventions. For the analyses
of the follow-up effects, we used the comparison with the psychoeducation group, on the basis
of which intervention was used more commonly for the treatment of depression/anxiety [30].
Quality of included studies
CTAM scores ranged from 29 to 82 (Table 1, last column), with only three out of eighteen
studies considered to be of adequate quality, with a CTAM score of at least 65 [79, 90, 93].
Of the eighteen RCTs, all but one [83] started out with true randomization (of which six
did not describe the process of randomization [80, 81, 82, 85, 91, 94]). One study became
quasi-randomized throughout the trial, as participants were moved to the control group after
randomization because of inability to do yoga [84].
Six studies reported the use of independent assessors who were blind to group allocation
[79, 80, 85, 87, 90, 93]. In all but three studies the intervention was adequately described [78,
Table 3. Hierarchy of preferred depression measurement scales.
Ranking Measurement Scale Source for ranking
1 Hamilton Depression Rating Scale [98]
2 Quick Inventory of Depressive Symptomatology [98]
3 Patient Health Questionnaire-9 [99]
4 Center of Epidemiological Studies Depression Scale [100]
5 Profile of Mood States [101]
6 Edinburgh Postnatal Depression Scale [102]
7 Cornell Dysthymia Rating Scale [103]
https://doi.org/10.1371/journal.pone.0204925.t003
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93, 94], with ten of these using a treatment manual [79–82, 86, 87, 89–92]. In four studies, the
dropout was not reported [78, 80, 81, 85]. In the other studies, the dropout ranged from 0% to
47%, with a mean dropout rate of 18%. At follow-up, dropout rates ranged from 14% to 67%,
with a mean of 26%. One study had a dropout rate of over 50% (67%, at one-year follow-up
[34]). Five studies used intention-to-treat analysis [89, 90, 92–94]. When intention-to-treat
data were available, they were used for the assessment of effect sizes.
Analysis of the overall effects
Depression: Yoga vs. an active control condition (all, psychoeducation, and other) or
TAU. To compare the effects of yoga on symptoms of depression compared to an active con-
trol group, we used all eleven RCTs from which we had data [35, 79–82, 86–90, 93]. We found
an overall effect size of Cohen’s d -0.13 (95% CI = -0.49, 0.22). This effect was not significant
(p = 0.47; Fig 2). I2 was high and estimated at 77% (95% CI = 43, 94). The q-statistic assessing
heterogeneity was significant (Q(10) = 29.78, p< 0.001), indicating that there was a significant
heterogeneity amongst the included studies.
Fig 2. Effect of yoga versus all active control conditions on depressive symptoms.
https://doi.org/10.1371/journal.pone.0204925.g002
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In our sub-analyses, to compare the effects of yoga on symptoms of depression to a psy-
choeducation control group, we used all six RCTs for which data were obtained [81–82, 86, 87,
89, 90]. We found an overall effect size of Cohen’s d -0.52 (95% CI = -0.96, -0.08). This effect
was significant (p = 0.02; Fig 3). I2 was moderate and estimated at 56% (95% CI = 0, 92). The
q-statistic assessing heterogeneity was not significant (Q(5) = 10.71, p = 0.06), indicating that
there was no significant heterogeneity amongst the included studies. To compare the effects of
yoga on symptoms of depression compared to other active control groups, we used all six
RCTs from which we had data [35, 79, 80, 87, 88, 97]. We found an overall effect size of
Cohen’s d 0.28 (95% CI = -0.07, 0.63). This effect was not significant (p = 0.12; Fig 4). I2 was
moderate to high and estimated at 65% (95% CI = 8, 95). The q-statistic assessing heterogene-
ity was significant (Q(5) = 14.31, p = 0.01). This indicates that the included studies were
heterogeneous.
To compare the effects of yoga on symptoms of depression compared to TAU, we used five
RCTs [80, 88, 92–94]. The overall effect size found was Cohen’s d -0.64 (95% CI = -1.41, 0.13),
which was not significant (p = 0.10; Fig 5). I2 was high and estimated at 93% (95% CI = 76, 99).
The q-statistic assessing heterogeneity was significant (Q(4) = 27.51, p< 0.001), again indicat-
ing significant heterogeneity amongst studies. As we found only two RCTs assessing symp-
toms of depression in chronic and/or treatment-resistant patients, no separate analyses for the
chronic group were performed.
To compare the long-term effects of yoga on symptoms of depression to an active control
group, we used four RCTs that had data from a follow-up of six months or longer [34, 87, 90,
Fig 3. Effect of yoga versus psychoeducation control conditions on depressive symptoms.
https://doi.org/10.1371/journal.pone.0204925.g003
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Fig 4. Effect of yoga versus other active control conditions on depressive symptoms.
https://doi.org/10.1371/journal.pone.0204925.g004
Fig 5. Effect of yoga versus TAU on depressive symptoms.
https://doi.org/10.1371/journal.pone.0204925.g005
Hatha yoga for mood and anxiety disorders
PLOS ONE | https://doi.org/10.1371/journal.pone.0204925 October 1, 2018 16 / 28
97]. We found an overall effect size of Cohen’s d -0.14 (95% CI = -0.60, 0.33). This effect was
not significant (p = 0.56; Fig 6). I2 was high and estimated at 78% (95% CI = 17, 99). The q-sta-
tistic assessing heterogeneity was significant (Q(3) = 11.35, p = 0.01), indicating that there was
a significant heterogeneity amongst the included studies.
Anxiety: Yoga vs. an active control condition. To compare the effects of yoga on symp-
toms of anxiety compared to active control groups, we used all five RCTs for which data were
obtained [79, 80, 85, 86, 88]. The overall effect size was Cohen’s d -0.09 (95% CI = -0.47, 0.30),
which was not significant (p = 0.65; Fig 7). I2 was moderate to high and estimated at 63% (95%
CI = 0, 96%). The q-statistic assessing heterogeneity was significant (Q(4) = 10.34, p = 0.04).
This indicates that the included studies were heterogeneous. As we found only five RCTs for
anxiety, no separate analyses for yoga versus TAU, psychoeducation or other active control
groups were performed. Also, we found only one RCT assessing symptoms of anxiety in
chronic and/or treatment-resistant patients and only one RCT assessing effects after a follow-
up of six months or more; therefore, no separate analysis for these groups were performed.
Publication bias
Due to the low number of studies and the significant amount of heterogeneity, the Egger’s test
for small-study effects was not computed in line with recommendations for meta-analyses
Fig 6. Long term effects of yoga versus active control conditions on depressive symptoms.
https://doi.org/10.1371/journal.pone.0204925.g006
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[104]. Instead, publication bias was visually inspected using funnel plots. The funnel plot of
studies examining the effect of yoga versus control conditions (both active and TAU) on
depression (Fig 8) shows some evidence of funnel plot asymmetry, which may indicate a publi-
cation bias but could also be a result of significant heterogeneity amongst studies. Similarly,
the funnel plot for studies examining the effect of yoga versus a control condition on anxiety
(Fig 9) demonstrates some indication of funnel plot asymmetry, again due to either publica-
tion bias or heterogeneity amongst studies. Given the low number of studies in this meta-anal-
ysis, we cannot draw formal conclusions on the presence of a publication bias.
Qualitative description
Effects for chronic and/or treatment-resistant populations. The number of studies in
chronic and/or treatment-resistant patients was too low to perform separate analyses for the
meta-analysis. As the possible effect of yoga for this population is important, we qualitatively
reviewed the effects found in the four studies [83, 85, 87, 90]. One study was conducted with
52 patients with dysthymia, double depression and/or major depressive disorder, being symp-
tomatic for over two years without significant remission of two months or more [87]. These
authors found no significant difference between the yoga group and control group (psycho-
education sessions) at six and nine months post-treatment (a 12-week intervention) on level of
Fig 7. Effect of yoga versus active control condition on symptoms of anxiety.
https://doi.org/10.1371/journal.pone.0204925.g007
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Fig 8. Funnel plot of included studies for depression.
https://doi.org/10.1371/journal.pone.0204925.g008
Fig 9. Funnel plot of included studies for anxiety.
https://doi.org/10.1371/journal.pone.0204925.g009
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symptoms of depression. At nine months post-treatment they did find a significant difference
in number of remissions between the yoga group and the control group with more patients in
the yoga group reporting a remission (defined as not having a mood disorder of at least two
months) with a medium-large effect size of -0.41 (Cramer’s V). They also found that in the
yoga group, compared to the control group, fewer people were in a new major depression epi-
sode. Although this difference was not significant at the level of p = 0.05, they found a medium
effect size of 0.34 (Cramer’s V).
One study included 122 patients, with two thirds of the sample having chronic major
depression, reporting symptoms over the past two years with absence of remission over two
months [90]. The results indicated no significant difference between the yoga group and con-
trol group (health education classes) at post-treatment (ten weeks) on level of symptoms of
depression. At six months follow-up there was a significant difference favoring the yoga group
with a medium effect size (Cohen’s d of 0.50) on level of symptoms of depression. The study
found no significant difference of full remissions between the yoga and control groups at six
months follow-up.
One study included 27 patients with treatment-resistant psychoneurosis or depression,
without response to conventional treatments [85], and found a significant difference in symp-
toms of anxiety between the yoga group and control group (relaxation resembling yoga) four
weeks post-treatment in favor of the yoga group with a large effect size of 1.63 (Cohen’s d).
One study included 12 patients of whom the majority were diagnosed with chronic generalized
anxiety disorder (3–5 years of disorder) and found no difference in symptoms of anxiety
between a yoga group and a control group of naturopathy (various massage techniques and
breathing practices) after 21 days of treatment [83].
These four studies showed that participants in a yoga intervention reported more remis-
sions than a control group at 9-months follow-up, but not fewer symptoms of depression [87],
more decrease in symptoms of depression compared to a control group at 6-months follow-
up, but not immediately after the intervention [90], more decrease in symptoms of anxiety
four weeks after the intervention compared to a control group of relaxation resembling yoga
[85], and no difference between a yoga group and a control group of naturopathy [83].
Although the studies reported mixed results, most of them showed that yoga might have some
promise for patients with chronic forms of mood and anxiety disorder, especially at longer
periods of follow-up.
Discussion
This systematic review and meta-analysis was conducted to investigate whether hatha yoga is
an effective treatment for acute, chronic and/or treatment-resistant mood and anxiety disor-
ders. Through a systematic search we found eighteen studies investigating hatha yoga for
mood and anxiety disorders, fifteen in acute patients and three in chronic and/or treatment-
resistant patients. Three out of eighteen were of high methodological quality according to the
CTAM [72]. The data of thirteen RCTs could be included in the analyses. Our findings showed
no significant effect for hatha yoga on symptoms of depression compared to treatment as
usual or compared to all active control groups. However, a comparison of yoga to psychoedu-
cation control showed that hatha yoga led to reductions of symptoms of depression. For
depression, at six months follow up or longer, we did not find a significant effect for hatha
yoga compared to active control condition. Further, our findings show no significant effect for
hatha yoga on symptoms of anxiety compared to active control groups.
Our results contrast with previous findings of yoga’s effectiveness in reducing symptoms in
mood and anxiety disorders [51–59]. A previous meta-analysis on yoga for depression found
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medium-large effect sizes for yoga compared to usual care (standardized mean difference
(SMD) of -0.69), for yoga compared to relaxation (SMD of -0.62), and for yoga compared to
exercise (SMD of -0.59) [51]. An earlier meta-analysis on yoga for anxiety found small effect
sizes for yoga compared to no treatment (SMD of -0.43) and large effect sizes for yoga com-
pared to active control groups (SMD of -0.86) [59]. The discrepancy between these results and
our own findings may be due to various methodological differences. First, the current meta-
analysis focused on hatha yoga in contrast to both meta-analyses by Cramer et al. [51, 59], in
which only six of the twelve studies [51] and seven out of eight studies [59] used hatha yoga.
The Cramer meta-analyses are thus limited in their ability to draw conclusions specifically
regarding hatha yoga interventions. It is possible that other forms of yoga are more effective
for mood disorders. This is a conclusion drawn by Cramer et al. [51], who found that medita-
tion-based yoga interventions were more effective than exercise-based yoga interventions. Sec-
ond, the current meta-analysis focused on clinical samples whereas five of the twelve RCTs in
Cramer et al. [51] and three out of the eight RCTs in Cramer et al. [59] used non-clinical sam-
ples, limiting the ability to generalize these findings to clinical populations. The discrepant
findings between the current results and those of Cramer et al. could indicate that yoga is
more effective in subthreshold symptomatology in the general populations and less effective in
patients diagnosed with mood and anxiety disorders. Third, a number of studies in our meta-
analysis either used samples including both mood and anxiety disorder patients [88, 93], or
used a sample of homogenous participants (i.e., either mood or anxiety patients) but collected
outcome measures for both mood and anxiety symptoms [34, 79, 80]. Given that participants
in these samples were not required to have elevated levels of both depression and anxiety at
baseline, they may have had lower scores on one measure, restricting the amount of room for
improvement. However, we checked the mixed samples studies, and found that, on average,
participants scored above the clinical cut-off scores on both anxiety and depression, leaving
enough room for changes in the mean scores.
Considering the effects of hatha yoga for chronic and/or treatment-resistant populations,
our qualitative review shows that participants in a yoga intervention reported more remissions
than a control group at 9-months follow-up but no change in level of symptoms of depression
at 9-months follow-up [87], more decrease in symptoms of depression compared to a control
group at 6-months follow-up, but not immediately after the intervention [90], more decrease
in symptoms of anxiety four weeks after the intervention compared to a control group [85],
and no difference between a yoga group and a control group of naturopathy [83]. Given these
mixed findings, conclusions are hard to draw but it seems that yoga interventions might be
effective for patients with chronic and/or treatment resistant mood and anxiety disorders at a
longer follow-up.
Limitations of the current study
One important limitation on interpreting the results, consists of the quality of the studies
included in the analyses. Specifically, only three of the eighteen studies had good methodologi-
cal quality [79, 90, 93]. In the remaining fifteen studies, the quality was low to moderate due to
a number of reasons such as a lack of (1) assessment by independent assessors, (2) assessment
carried out blind to the treatment allocation, (3) intention-to-treat analysis, (4) an adequate
description of the intervention or the use of a manualized intervention, and (5) insufficient
sample size. Also, the results of three studies were not included in the meta-analysis as the
authors did not provide the requested data. Further, the included studies were heterogeneous
with regard to type of clinical population, amount and length of yoga practice, yoga ingredi-
ents, and control group. This heterogeneity was demonstrated in the I2 and Q-statistic of
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comparisons in this study, indicating the results should be carefully interpreted as each factor
could moderate the meta-analytic effects. Given the low number of studies we were not able to
investigate this potential moderation.
Moreover, several studies described the intervention as yoga without being specific regard-
ing why the intervention was considered to be yoga-based. Although a prototypical hatha yoga
practice would include instructions that elicit a mind state based on yoga theory (e.g., encour-
aging a mindful awareness, a connection between body and mind), it is possible that in some
cases the yoga postures are administered essentially as stretching practices. We recommend
that future publications include sufficient information about the yoga intervention so that
potential instructional moderators can be examined. Another issue regarding interpretation is
the heterogeneous types of control groups. Given that some of the control conditions have
been found to be effective in treating depression (e.g., aerobic exercise and mindfulness), their
inclusion as active controls will lessen the likelihood of finding effects for yoga. We found evi-
dence for this perspective in our sub-analysis that omitted control groups that clearly involved
a therapeutic element over and above non-specific factors (i.e., mindfulness, aerobic exercise,
walking, and a group therapy intervention) in order to compare hatha yoga with psychoeduca-
tion. The results indicated that compared to psychoeducation controls, hatha yoga showed a
benefit on depression symptoms.
One more factor of importance is that, only five of the included interventions used yoga
programmes designed specifically for patients with mood and anxiety disorders [35, 82, 86, 89,
92]. This might limit the effectiveness of yoga interventions in general. For example, findings
have shown that a mindfulness intervention designed specifically for depressed patients
(MBCT) was effective in reducing symptoms of depression in patients with acute disorders
where a general mindfulness intervention (MBSR) was not [105]. This suggests potential prob-
lems in using more general yoga interventions for treating mood and anxiety disorders, and
emphasizes a need to study yoga interventions that are specifically designed to target mood
and anxiety disorders.
A last limitation of note is that we had too few studies to examine publication bias using
Egger’s tests. Instead, funnel plots were visually inspected, which indicated a slight asymmetry.
Although this asymmetry could imply publication bias, this meta-analysis has too little studies
to draw formal conclusions on this matter. This is a significant limitation as a presence of pub-
lication bias would imply our results cannot be reliably interpreted. Given the funnel plots
indicated a slight publication bias, yet cannot be formally inspected due to the small N of this
study, we again urge that our results are interpreted with caution. More high-quality research
is needed to reliably determine the effect of yoga on depressive/anxiety symptoms compared
to TAU and active control interventions.
Clinical implications and further research
Our main conclusion is that there is not enough solid evidence for hatha yoga to be considered
an effective treatment for mood and anxiety disorders. Therefore, no recommendations for
clinical practice can be made. More RCTs are needed using methodology in accordance with
the Clinical Trials Assessment Measure for psychological treatments [72] to examine the effec-
tiveness of hatha yoga interventions for the treatment of acute, chronic and/or treatment-resis-
tant mood and anxiety disorders. Such studies would benefit from making use of the guidelines
of conducting clinical trials as described in the CONSORT statement [106]. We also recom-
mend the publication of studies using open access and making the data online available.
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